Representatives of the Trump administration have “pushed hard” for pro-US drug pricing reforms in free trade negotiations with the UK government, according to leaked documents posted online
Patients in England are to get easier access to Merck KGaA’s multiple sclerosis drug Mavenclad after NICE dropped requirements for a special MRI scan before prescription.
